Hennessey Venom F5
2021–present

—
Market value · recent verified sales
MSRP
—
Collectibility
10/10
Holy Grail
3-Year Forecast
—
Not enough sales data
5-Year Forecast
—
Not enough sales data
Market scores
30
Desirability
Illiquid
10
Liquidity
Moderate
50
Resale Outlook
Marque analyst note
The Hennessey Venom F5 remains one of the most exclusive hypercars on the road, with only 24 units produced globally, placing it firmly in the "Holy Grail" collectibility tier. The extreme scarcity and engineering pedigree of the model suggest inherent long-term appeal, though transactional data in the UK market is too sparse to establish reliable pricing trends or momentum signals at present.
No secondary-market sales of the Venom F5 have been tracked in the UK over the past 12 months, and no active listings are currently recorded. This absence of transaction flow reflects both the car's ultra-limited production run and the reality that owners rarely part with vehicles of this rarity and performance specification.
The lack of measurable liquidity means buyers and sellers should expect considerable friction in any potential transaction. Pricing discovery will depend heavily on direct negotiation with private holders, and comparables from other global markets may offer the best reference points until UK sales activity emerges.
Without sufficient transaction history, forward projections cannot be reliably estimated at this time. Market sentiment will likely be shaped by broader hypercar demand, the car's continued technical relevance, and the owner-retention patterns that typically define vehicles at this level of exclusivity.
Depreciation Benchmark
- Segment average+3.0 to +9.5%/yr
Est. Annual Ownership Costs
- Insurance (agreed value)£450
- Maintenance£900
- Storage£2,400
- Depreciation— (appreciating)
- Total annual cost£3,750
Market Liquidity
- Active Listings0
- Sales Last 12 Months0
Market Snapshot
- Active Listings0
- Avg Sale Price—
- Avg Mileage at Sale—
- Recent Price Range—
- Total Sales Tracked0
Recent sales
Indicative only — not investment advice. Past performance is not a reliable indicator of future value.